Research News and Research

RSS

Pfizer-FRSQ-MSSS Chronic Disease Fund for chronic-disease prevention and management initiatives

The Fonds de la recherche en santé du Québec in partnership with the Ministère de la Santé et des Services sociaux and Pfizer Canada, is announcing the creation of the Pfizer-FRSQ-MSSS Chronic Disease Fund. Established with an investment of $5 million from Pfizer Canada, this research grant program, coordinated by the FRSQ, is open to Quebec-based researchers who work in collaboration with health professionals.

17 Mar 2010

Researchers explore new tools to mitigate risk of radiation exposure

Doctors have a clearer picture than ever before of how much radiation reaches sensitive tissues during routine X-rays and similar imaging, thanks to sophisticated models of the human body being developed at the University of Florida.

17 Mar 2010

Study: Jump in number of California's uninsured

"The state's uninsured population jumped to 8.2 million in 2009, up from 6.4 million in 2007, marking the highest number over the last decade, investigators from UCLA's Center for Health Policy Research said," the Los Angeles Times reports.

17 Mar 2010

Acetaminophen safe and effective for reducing postpartum pain

For many mothers of newborns, lingering pain from the delivery can interfere with their first days with their infant. A recent review examined whether over-the-counter medications containing acetaminophen - Tylenol for example − provided adequate relief for such pain and concluded that they are effective.

17 Mar 2010

Research shows clove is the best antioxidant spice

Using spices eaten in the Mediterranean diet as natural antioxidants is a good way forward for the food industry, given the beneficial health effects of these products. This has been shown by researchers from the Miguel Hern-ndez University (UMH), who have put the clove in first place.

17 Mar 2010

School environment plays a big role in girls' weight-control behaviors

Their schoolmates' weight determines whether teenage high school girls will try to lose pounds, new research finds, and the school environment plays a big role in the decision.

17 Mar 2010

Health ad campaigns emerge in final days of debate

As Congress approaches a possible finale to its year-long health debate, advertisements that attempt to influence the results have flooded airwaves, Time reports. "Across the country, groups on all sides of the health care reform debate have been targeting swing members of Congress with costly ad campaigns." Firms, industry groups, unions and advocacy organizations could spend $24 million this week alone, on top of $200 million already spent on health overhaul-related ads (Scherer, 3/16).

16 Mar 2010

Human amniotic fluid skin cells "reprogrammed" to pluripotency

In a breakthrough that may help fill a critical need in stem cell research and patient care, researchers at Mount Sinai School of Medicine have demonstrated that skin cells found in human amniotic fluid can be efficiently "reprogrammed" to pluripotency, where they have characteristics similar to human embryonic stem cells that can develop into almost any type of cell in the human body. The study is online now and will appear in print in the next issue of the journal Cellular Reprogramming, to be published next month.

16 Mar 2010

External beam radiotherapy device without shielded bunker infrastructure for breast cancer irradiation

Orbital Therapy has completed the build of their proof-of-concept prototype for breast cancer irradiation, and demonstrated the feasibility to develop and operate an external beam radiotherapy device without the use of a heavily shielded bunker infrastructure.

16 Mar 2010

Optics Balzers acquires mso jena Mikroschichtoptik

Optics Balzers, a leading supplier of innovative optical thin-film components and assemblies, is continuing its growth in great strides. With its acquisition of “mso jena Mikroschichtoptik GmbH” in Jena, Germany, it is expanding its competencies and manufacturing technologies into a unique portfolio.

16 Mar 2010

LUMC purchases Fluidigm Access Array system

Fluidigm Corporation and BIOKÉ, distributor of Fluidigm systems in the Benelux, today announced that Leiden University Medical Center’s (LUMC) Human Genetics Department has purchased a Fluidigm Access Array™ system. The Access Array system enables users to automatically prepare sequencing-ready libraries from up to 48 individual samples at a time, for as little as €7 (EUR) per sample.

16 Mar 2010

Sigma-Aldrich signs agreement to acquire Ace Animals

Sigma-Aldrich® today announced it has signed an agreement to acquire Ace Animals, Inc., a Berks County, PA.-based provider of high quality research rodents to the biomedical industry.

16 Mar 2010

Tolerx publishes follow-up data from study of otelixizumab therapy for new onset T1DM patients

Tolerx, Inc., today announced the publication in Diabetologia, the journal of the European Association for the Study of Diabetes, of the four-year follow-up clinical data from new onset type 1 diabetes (T1DM) patients (age 12-39) who received a single short course of therapy with otelixizumab (ChAglyCD3).

16 Mar 2010

NextGen Healthcare Information Systems executes agreement with WSUPG to deploy NextGen Practice Solutions

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and leading provider of healthcare information systems and connectivity solutions, today announced it has executed an agreement with Wayne State University Physician Group to deploy NextGenSM Practice Solutions, a line of business devoted to providing healthcare organizations with cost-effective revenue cycle management (RCM) services.

16 Mar 2010

Mission Pharmacal, March of Dimes to distribute healthy pregnancy, healthy baby education materials

Mission Pharmacal announced today that it will partner with the March of Dimes to distribute healthy pregnancy and healthy baby education materials to more than 15,000 obstetricians and gynecologists nationwide to help more babies be born healthy.

16 Mar 2010

Blocking RhoA enzyme increases survival in SMA mouse model

Scientists from the Ottawa Hospital Research Institute (OHRI) and the University of Ottawa have identified a promising new approach for developing drugs to treat Spinal muscular atrophy (SMA), the leading inherited cause of death in infants and toddlers. Dr. Rashmi Kothary and his doctoral student Melissa Bowerman have found that an enzyme called RhoA is overly active in a mouse model of the disease and blocking this enzyme can greatly increase survival. The study is published in Human Molecular Genetics.

16 Mar 2010

Viron Therapeutics' VT-346 anti-TNF protein exhibits positive results in transgenic mouse model for arthritis

Viron Therapeutics Inc. announced that VT-346, an anti-TNF protein therapeutic, demonstrated positive results in a pivotal proof of concept study in the gold standard transgenic mouse model for arthritis. VT-346 achieved a statistically significant, dose dependent impact in this preclinical model of arthritis and prevented deterioration due to disease in terms of weight gain, arthritic score and pathology parameters. VT-346 had particularly strong protective effects on therapeutically-important bone and cartilage damage in this model.

16 Mar 2010

Iverson Genetic Diagnostics to conduct WARFARIN clinical study

Iverson Genetic Diagnostics, Inc. today announced that they will conduct a WARFARIN clinical study to assess the efficacy of gene-based testing prior to initiating warfarin anticoagulation therapy to reduce the incidence of bleeding and thromboembolic events.

16 Mar 2010

Bovie Medical reports revenues totalling $6.5M for fourth-quarter 2009

Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced its financial results for the fourth quarter and year ended December 31, 2009.

16 Mar 2010

Cytheris study: rhIL-7 treatment restores T cell trafficking and improves survival in animal model of sepsis

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced publication of data from a preclinical study in a clinically relevant animal model of sepsis showing that recombinant human Interleukin-7 (rhIL-7) treatment not only restores T cell trafficking and function, but also translates into improved survival.

16 Mar 2010

Research News and Research

Pfizer-FRSQ-MSSS Chronic Disease Fund for chronic-disease prevention and management initiatives

Researchers explore new tools to mitigate risk of radiation exposure

Study: Jump in number of California's uninsured

Acetaminophen safe and effective for reducing postpartum pain

Research shows clove is the best antioxidant spice

School environment plays a big role in girls' weight-control behaviors

Health ad campaigns emerge in final days of debate

Human amniotic fluid skin cells "reprogrammed" to pluripotency

External beam radiotherapy device without shielded bunker infrastructure for breast cancer irradiation

Optics Balzers acquires mso jena Mikroschichtoptik

LUMC purchases Fluidigm Access Array system

Sigma-Aldrich signs agreement to acquire Ace Animals

Tolerx publishes follow-up data from study of otelixizumab therapy for new onset T1DM patients

NextGen Healthcare Information Systems executes agreement with WSUPG to deploy NextGen Practice Solutions

Mission Pharmacal, March of Dimes to distribute healthy pregnancy, healthy baby education materials

Blocking RhoA enzyme increases survival in SMA mouse model

Viron Therapeutics' VT-346 anti-TNF protein exhibits positive results in transgenic mouse model for arthritis

Iverson Genetic Diagnostics to conduct WARFARIN clinical study

Bovie Medical reports revenues totalling $6.5M for fourth-quarter 2009

Cytheris study: rhIL-7 treatment restores T cell trafficking and improves survival in animal model of sepsis

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest Life Science News